Personal Protective Equipment

U.S. hospitals recorded nearly 58,000 work-related injuries and illnesses in 2013, amounting to 6.4 work-related injuries and illnesses for every 100 full-time employees -- almost twice as high as the overall rate for private industry. In June, the Occupational Safety and Health Administration (OSHA) announced it was targeting some of the most common causes of workplace injury and illness in the healthcare industry, and is expanding its use of enforcement resources in hospitals and nursing homes to focus on patient or resident handling; bloodborne pathogens; workplace violence; tuberculosis, and slips, trips and falls.

Johns Hopkins University and DuPont have signed license and collaboration agreements allowing DuPont to commercialize a garment with innovative features from Johns Hopkins to help protect people on the front lines of the Ebola crisis and future deadly infectious disease outbreaks. DuPont intends to have the first of these garments available in the marketplace during the first half of 2016.

Infection Control Today invited manufacturers of personal protective equipment (PPE) and antimicrobial textiles to share their perspectives on key issues relating to pandemic preparedness as well as proper donning and doffing techniques.

NIOSH and the National Personal Protective Technology Laboratory (NPPTL) announce the release of three documents related to respiratory protection in healthcare.

If you’re allergic to natural rubber latex, the Food and Drug Administration (FDA) has good news for you: in the future, you are less likely to be misinformed about the absence of this allergen in such products as medical devices. To avoid false assurances about this hazard, the FDA is recommending to manufacturers to stop using the labels “latex free” or “does not contain latex.” The reason for this recommendation is that the agency is not aware of any tests that can show a product contains no natural rubber latex proteins that can cause allergic reactions

Ebola virus disease presents a unique occupational health challenge to healthcare institutions, and Ebola readiness and response can drain al-ready-scarce infection prevention resources. This is reflected in a recent survey of infection preventionists at U.S. hospitals conducted by the Association for Professionals in Infection Control and Epidemiology (APIC) in which only 6 percent of healthcare institutions are well-prepared to receive a patient with the Ebola virus. Infection preventionists everywhere are hoping that the Ebola crisis can shed new light on the importance of a properly funded and resourced department.

The Centers for Disease Control and Prevention (CDC) has ordered $2.7 million in personal protective equipment (PPE) to increase Strategic National Stockpile (SNS) supplies to assist U.S. hospitals caring for Ebola patients. Products are being configured into 50 kits that can be rapidly delivered to hospitals. Each kit can provide the PPE needed by clinical teams to manage the care of one Ebola patient for up to five days.

In the days of home births, hot water and clean towels - gloves for use during patient exams began during the 1760s when physicians used obstetric gloves made from sheep intestines for vaginal exams in Germany. It wasn’t until the 1840s when Charles Goodyear patented his “vulcanized” rubber that surgical gloves became flexible enough to wear and in some iteration were used en mass by nurses at Johns Hopkins Hospital in the 1890s after surgeon Dr. William Halstead published his paper, “The Treatment of Wounds.”